Natural killer cell and gamma delta T cell alterations in enthesitis related arthritis category of juvenile idiopathic arthritis

Clinical Immunology

Volumn 161, Issue 2, 2015, Pages 163-169

  Gaur, Priyanka ^a   Misra, Ramnath ^a   Aggarwal, Amita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Childhood arthritis; Inflammation; Innate immune cells; Killer immunoglobulin like receptors; Perforin; Synovial fluid

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; PERFORIN; IL17A PROTEIN, HUMAN; KIR3DL1 PROTEIN, HUMAN; KIR3DL2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTHESITIS; ENTHESITIS RELATED ARTHRITIS; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; INTERFERON PRODUCTION; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL FLUID; TH17 CELL; CASE CONTROL STUDY; IMMUNOLOGY; T LYMPHOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; ARTHRITIS, JUVENILE; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; KILLER CELLS, NATURAL; MALE; PERFORIN; RECEPTORS, KIR3DL1; RECEPTORS, KIR3DL2; SYNOVIAL FLUID; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84942582263     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2015.07.012     Document Type: Article

References (40)

1. Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J. Rheumatol. 2004, 31:390-392.
2. Kunjir V., Venugopalan A., Chopra A. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study. J. Rheumatol. 2010, 37:1756-1762.
3. Mahendra A., Misra R., Aggarwal A. Th1 and Th17 predominance in the enthesitis-related arthritis form of juvenile idiopathic arthritis. J. Rheumatol. 2009, 36:1730-1736.
4. Roark C.L., Simonian P.L., Fontenot A.P., Born W.K., O'Brien R.L. Gammadelta T cells: an important source of IL-17. Curr. Opin. Immunol. 2008, 20:353-357.
5. Cua D.J., Tat C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010, 10:479-489.
6. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
7. Fehniger T.A., Cooper M.A., Nuovo G.J., Cella M., Facchetti F., Colonna M., et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003, 101:3052-3057.
8. Soderstrom K., Stein E., Colmenero P., Purath U., Müller-Ladner U., de Matos C.T., et al. Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13028-13033.
9. Pridgeon C., Lennon G.P., Pazmany L., Thompson R.N., Christmas S.E., Moots R.J. Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright, CD94bright, CD158negative phenotype. Rheumatology (Oxford) 2003, 42:870-878.
10. de Matos C.T., Berg L., Michaëlsson J., Felländer-Tsai L., Kärre K., Söderström K. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology 2007, 122:291-301.
11. Zhang A.L., Colmenero P., Purath U., Teixeira de Matos C., Hueber W., Klareskog L., et al. Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood 2007, 110:2484-2493.
12. Chan A.T., Kollnberger S.D., Wedderburn L.R., Bowness P. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin like receptor KIR3DL2 in spondyloarthritis. Arthritis Rheum. 2005, 52:3586-3595.
13. Roark C.L., French J.D., Taylor M.A., Bendele A.M., Born W.K., O'Brien R.L. γδ T cells clonally expand, produce IL-17, and are pathogenic in collagen-induced arthritis. J. Immunol. 2007, 179:5576-5583.
14. Ito Y., Usui T., Kobayashi S., Iguchi-Hashimoto M., Ito H., Yoshitomi H., et al. Gamma delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum. 2009, 60:2294-2303.
15. Kenna T.J., Davidson S.I., Duan R., Bradbury L.A., McFarlane J., Smith M., et al. Enrichment of circulating interleukin-17- secreting interleukin-23 receptor-positive gamma delta T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 2012, 64:1420-1429.
16. Myles A., Tuteja A., Aggarwal A. Synovial fluid mononuclear cell gene expression profiling suggests dysregulation of innate immune genes in enthesitis-related arthritis patients. Rheumatology 2012, 51:1785-1789.
17. Mendes R., Bromelow K.V., Westby M., Galea-Lauri J., Smith I.E., O'Brien M.E.R., et al. Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood. Cytometry 2000, 39:72-78.
18. Park Y.W., Kee S.J., Cho Y.N., Lee E.H., Lee H.Y., Kim E.M., et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum. 2009, 60:1753-1763.
19. Spadaro A., Scrivo R., Moretti T., Bernardini G., Riccieri V., Taccari E., et al. Natural killer cells and gamma/delta T cells in synovial fluid and in peripheral blood of patients with psoriatic arthritis. Clin. Exp. Rheumatol. 2004, 22:389-394.
20. Grom A.A., Villanueva J., Lee S., Goldmuntz E.A., Passo M.H., Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J. Pediatr. 2003, 142:292-296.
21. Villanueva J., Lee S., Giannini E.H., Graham T.B., Passo M.H., Filipovich A., et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res. Ther. 2005, 7:R30-R37.
22. Ottaviani C., Nasorri F., Bedini C., de Pità O., Girolomoni G., Cavani A. CD56 bright CD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur. J. Immunol. 2006, 36:118-128.
23. Aramaki T., Ida H., Izumi Y., Fujikawa K., Huang M., Arima K., et al. A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis. Mod. Rheumatol. 2009, 19:245-252.
24. Scrivo R., Morrone S., Spadaro A., Santoni A., Valesini G. Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single-cell level. Cytometry B Clin. Cytom. 2011, 80:22-27.
25. de Rham C., Ferrari-Lacraz S., Jendly S., Schneiter G., Dayer J.M., Villard J. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis Res. Ther. 2007, 9:R125.
26. Mantle D., Falkous G., Walker D. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin. Chim. Acta 1999, 284:45-58.
27. Huard B., Karisson L., Triebel F. KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation. Eur. J. Immunol. 2001, 31:1728-1735.
28. Schlegel P.M., Steiert I., Kotter I., Müller C.A. B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls. PLoS One 2013, 8(12). (art. no. e82580).
29. Lo C.K., Lam Q.L., Sun L., Wang S., Ko K.H., Xu H., et al. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum. 2008, 58:2700-2711.
30. Saxena N., Misra R., Aggarwal A. Is the enthesitis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis?. Rheumatology 2006, 45:1129-1132.
31. Sutton C.E., Lalor S.J., Sweeney C.M., Brereton C.F., Lavelle E.C., Mills K.H., et al. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
32. Casetti R., Perretta G., Taglioni A., Mattei M., Colizzi V., Dieli F., et al. Drug-induced expansion and differentiation of Vγ9Vδ2 T cells in vivo: the role of exogenous IL-2. J. Immunol. 2005, 175:1593-1598.
33. Kühl A.A., Loddenkemper C., Westermann J., Hoffmann J.C. Role of gamma delta T cells in inflammatory bowel disease. Pathobiology 2002-2003, 70:150-155.
34. Flatz L., Conrad C. Role of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapy. Psoriasis: Targets Ther. 2013, 3:1-10.
35. Berkun Y., Bendersky A., Gerstein M., Goldstein I., Padeh S., Bank I. Gamma delta T cells in juvenile idiopathic arthritis: higher percentages of synovial Vdelta1+ and Vgamma9+ T cell subsets are associated with milder disease. J. Rheumatol. 2011, 38:1123-1129.
36. Hu C., Qian L., Miao Y., Huang Q., Miao P., Wang P., et al. Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis. Cell. Mol. Immunol. 2012, 9:245-254.
37. Wang L., Das H., Kamath A., Bukowski J.F. Human V gamma 2V delta 2 T cells produce IFN-gamma and TNF-alpha with an on/off/on cycling pattern in response to live bacterial products. J. Immunol. 2001, 167:6195-6201.
38. Ribot J.C., deBarros A., Pang D.J., Neves J.F., Peperzak V., Roberts S.J., et al. CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17-producing γδ T cell subsets. Nat. Immunol. 2009, 10:427-436.
39. Wang T., Scully E., Yin Z., Kim J.H., Wang S., Yan J., et al. IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J. Immunol. 2003, 171:2524-2531.
40. Takano M., Nishimura H., Kimura Y., Mokuno Y., Washizu J., Itohara S., et al. Protective roles of gamma delta T cells and interleukin-15 in Escherichia coli infection in mice. Infect. Immun. 1998, 66:3270-3278.